Jazz Pharmaceuticals (JAZZ) Change in Taxes (2012 - 2026)

Jazz Pharmaceuticals' Change in Taxes history runs 15 years deep, the most recent figure standing at $37.4 million for Q1 2026.

• In Q1 2026, Change in Taxes rose 187.69% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $61.6 million (up 471.23% YoY), while the FY2025 annual figure was $37.2 million, up 352.5% from the prior year.
• Change in Taxes was $37.4 million for Q1 2026 at Jazz Pharmaceuticals, up from -$34.8 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $46.3 million in Q2 2025 to a low of -$35.9 million in Q4 2023.
• Historically, Change in Taxes has averaged $4.9 million across 5 years, with a median of $12.7 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Change in Taxes tumbled 2264.41% in 2023, then jumped 1358.7% in 2025.
• A 5-year view of Change in Taxes shows it stood at -$1.5 million in 2022, then sank by 2264.41% to -$35.9 million in 2023, then grew by 3.06% to -$34.8 million in 2024, then climbed by 0.16% to -$34.8 million in 2025, then jumped by 207.52% to $37.4 million in 2026.
• The last three Change in Taxes figures came in at $37.4 million (Q1 2026), -$34.8 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.